Recall Record

East Haven, CT, United States

Milbar Laboratories, Inc. recalls

3 recalls recorded since 2018, most recently on 9 October 2020. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)0
Terminated or completed3
Class I (FDA)0

Terminated Class II Drugs

Recall started
9 October 2020
Terminated
4 January 2023
Reason
GMP Deviations
Distribution
Product was distributed throughout the United States, including Puerto Rico and internationally.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0084-2021, D-0087-2021, D-0096-2021, D-0088-2021, D-0093-2021, D-0095-2021, D-0094-2021, D-0085-2021, D-0092-2021, D-0091-2021, D-0083-2021, D-0086-2021 and 2 more

Terminated Class III Drugs

Recall started
4 May 2018
Terminated
18 March 2019
Reason
Subpotent
Distribution
Product was distributed to physicians and internet sales throughout the United States and Hong Kong, Panama, UK, China, Jordan, Qatar, Kuwait, and Central America.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0832-2018, D-0833-2018

Terminated Class II Drugs

Recall started
4 May 2018
Terminated
26 June 2019
Reason
GMP Deviations
Distribution
Within the United States and Puerto Rico
Initiated
Voluntary: Firm initiated
Recall numbers
D-0814-2018, D-0813-2018, D-0811-2018, D-0812-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.